Aristotle University Of Thessaloniki (AUTH)
Ο ρόλος των αντινεοαγγειακών παραγόντων στο διαβητικό οίδημα της ωχράς
Abstract
dc:descriptionThe most exciting paradigm shift that we have experienced in the treatment of diabetic retinopathy has been the advent of the anti-VEGF therapy ranibizumab (Lucentis, Genentech) for diabetic macular edema (DME) The most significant effect that the RISE and RIDE data have had is that patients with center-involving DME have a good chance of substantially improving their vision vs what was possible with laser photocoagulation. (Brown et al,2013) Based on this study anti-VEGF agent is considered the first-line treatment for center-involving DME for many clinicians. However, for patients who present with localized edema that meets the ETDRS criteria, clinicians should use focal laser (Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1, Early Treatment Diabetic Retinopathy Study research group) .The visual acuity data, in the ETDRS study with laser showed that approximately 15% of patients gained 3 lines with laser, and in RISE and RIDE, approximately 40% of patients gained 3 lines with anti-VEGF. In our study we were able to show that combination treatment with laser and anti-VEGF was superior to laser monotherapy. We also showed that combination therapy reduced the number of injections during the second year of treatment and the need for laser with better outcomes in terms of BCVA and OCT thickness. Our suggestion is to start treatment with a loading dose of three monthly injections, and laser treatment on the third month. Then we suggest combination treatment with injections and laser on a prn basis. We found that there is still a role for thermal laser in DME. For noncentral DME, circinate exudates, extrafoveal disease, and other disease that meets the definition of classic clinically significant DME, laser is a reasonable first line treatment.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2015
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Papavasileiou, Evangelia
- Παπαβασιλείου, Ευαγγελία
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/35828